{{Rsnum
|rsid=11979476
|Gene=AHCYL2
|Chromosome=7
|position=129353915
|Orientation=plus
|GMAF=0.2764
|Gene_s=AHCYL2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 5.4 | 35.7 | 58.9
| HCB | 6.6 | 44.5 | 48.9
| JPT | 11.5 | 50.4 | 38.1
| YRI | 6.2 | 34.9 | 58.9
| ASW | 3.5 | 28.1 | 68.4
| CHB | 6.6 | 44.5 | 48.9
| CHD | 16.5 | 38.5 | 45.0
| GIH | 15.8 | 47.5 | 36.6
| LWK | 10.9 | 41.8 | 47.3
| MEX | 12.1 | 46.6 | 41.4
| MKK | 19.2 | 48.7 | 32.1
| TSI | 9.8 | 41.2 | 49.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22228203
|Trait=None
|Title=A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network.
|RiskAllele=
|Pval=0.000002
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}